James Van Der Beek Partners with Guardant Health for Colorectal Cancer Awareness
Actor James Van Der Beek, known for his roles in popular movies and TV shows, is partnering with Guardant Health to raise awareness about colorectal cancer (CRC) screening. This collaboration aims to highlight new advances in CRC screening, particularly for adults aged 45 and older.
Van Der Beek, who was diagnosed with stage 3 colorectal cancer, is sharing his story to encourage others to get screened. He emphasizes that early detection is crucial for successful treatment. According to Guardant Health, a significant percentage of patients who die from CRC are not screened, often because traditional screening methods are perceived as unpleasant or inconvenient.
Guardant's FDA-approved Shield blood test offers a more convenient alternative. It requires only a simple blood draw from a healthcare provider, making it easier for individuals at average risk for CRC to get screened.
The Importance of Screening
Van Der Beek stresses the importance of regular screening, even for those who feel healthy. "I was 46 years old, in great physical shape, and had no idea I was living with stage 3 colorectal cancer," he said. "It's the second most deadly cancer, but the most curable when caught in its early stages, making screening crucial."
Guardant Health's Shield Blood Test
The Shield blood test provides a more accessible screening option, potentially increasing screening rates and ultimately saving lives. By partnering with James Van Der Beek, Guardant Health hopes to reach a wider audience and encourage more people to take control of their health.
- Early detection is key to successful treatment.
- The Shield blood test offers a convenient screening option.
- Talk to your doctor about colorectal cancer screening guidelines.